Literature DB >> 16803694

Effects of statins on experimental colitis in normocholesterolemic rats.

Nermina Jahovic1, Nursal Gedik, Feriha Ercan, Serap Sirvanci, Meral Yüksel, Göksel Sener, Inci Alican.   

Abstract

OBJECTIVE: The results of previous studies suggest that statins have a direct anti-inflammatory effect that is not directly related to their cholesterol-lowering activity. The aim of this study was to investigate the effect of simvastatin (SIM) and fluvastatin (FLU) on trinitrobenzene sulfonic acid (TNBS)-induced colonic inflammation in rats.
MATERIAL AND METHODS: The drugs were given for 3 days (0.1 and 1 mg/kg day-1; intraperitoneally) after induction of colitis. The lesions in the distal colon were scored at the macroscopic and microscopic level. Tissue malondialdehyde (MDA) and glutathione (GSH) levels, myeloperoxidase (MPO) activity and collagen content were assessed and formation of reactive oxygen species and peroxynitrite was monitored by chemiluminescence (CL) assay. Trunk blood was collected for the measurement of serum tumor necrosis factor (TNF)-alpha level.
RESULTS: Treatment with SIM reduced the lesion score of the colitis group at macroscopic level (p<0.05), but there was no effect of treatment with FLU. The increase in colonic MDA level of the colitis group was reduced by both drugs at all doses (p<0.05-0.001). The decrease in GSH and the an increase in MPO activity in the colitis group were reversed by SIM at all doses (p<0.01), but FLU had no effect. An increase in colonic lucigenin CL value in the colitis group was reduced by SIM and FLU at all doses (p<0.001) and an increase in peroxynitrite ratio in the colitis group showed a significant reduction in SIM-treated groups; FLU reduced this effect at a dose of 1 mg/kg (p<0.01). An increase in tissue collagen content and serum TNF-alpha level in the colitis group was reversed by both drugs at all doses (p<0.001).
CONCLUSIONS: SIM and FLU seemed to be beneficial in a TNBS-induced rat colitis model through the prevention of lipid peroxidation, superoxide generation, cytokine production and neutrophil accumulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16803694     DOI: 10.1080/00365520600554444

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.

Authors:  O Grip; S Janciauskiene; A Bredberg
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

Review 2.  Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.

Authors:  David S Fedson
Journal:  Ann Transl Med       Date:  2016-11

3.  Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities.

Authors:  Göksel Sener; Halil Aksoy; Ozer Sehirli; Meral Yüksel; Cenk Aral; Nursal Gedik; Sule Cetinel; Berrak C Yeğen
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

4.  Evidence for simvastatin anti-inflammatory actions based on quantitative analyses of NETosis and other inflammation/oxidation markers.

Authors:  Walid M Al-Ghoul; Margarita S Kim; Nadeem Fazal; Anser C Azim; Ashraf Ali
Journal:  Results Immunol       Date:  2014-03-25

5.  Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation.

Authors:  Stefan Bereswill; Melba Muñoz; André Fischer; Rita Plickert; Lea-Maxie Haag; Bettina Otto; Anja A Kühl; Christoph Loddenkemper; Ulf B Göbel; Markus M Heimesaat
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

6.  Comparative protective effect of hawthorn berry hydroalcoholic extract, atorvastatin, and mesalamine on experimentally induced colitis in rats.

Authors:  Hassan Malekinejad; Vahid Shafie-Irannejad; Rahim Hobbenaghi; Seyed Hamed Tabatabaie; Seyed-Mehdi Moshtaghion
Journal:  J Med Food       Date:  2013-07       Impact factor: 2.786

7.  Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.

Authors:  Ryan Ungaro; Helena L Chang; Justin Côté-Daigneault; Saurabh Mehandru; Ashish Atreja; Jean-Frederic Colombel
Journal:  Am J Gastroenterol       Date:  2016-06-14       Impact factor: 10.864

8.  Simvastatin attenuates trinitrobenzene sulfonic acid-induced colitis, but not oxazalone-induced colitis.

Authors:  Maho Ikeda; Fuminao Takeshima; Hajime Isomoto; Saburo Shikuwa; Yohei Mizuta; Yoshiyuki Ozono; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2007-12-01       Impact factor: 3.199

9.  Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis.

Authors:  Tasneem Lokhandwala; Donna West-Strum; Benjamin F Banahan; John P Bentley; Yi Yang
Journal:  BMJ Open       Date:  2012-05-22       Impact factor: 2.692

10.  Simvastatin attenuates the lipopolysaccharideinduced inflammatory response of rat pulmonary microvascular endothelial cells by downregulating toll-like receptor 4 expression.

Authors:  Yi Li; Jian-Yong Ding; Biao-Xue Ge; Chang-Hong Miao
Journal:  Cent Eur J Med       Date:  2013-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.